MedPath

LIBTAYO

LIBTAYO

Approved
DIN Number

02487144

Drug Class

Human

Market Date

May 24, 2019

Company
HC

regeneron canada company

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02487144
AIG Number0161350001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01FF06 CEMIPLIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CEMIPLIMABActive
Strength: 350 MG / 7 ML
Monograph: CEMIPLIMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.